https://www.marketscreener.com/quote/stock/MAXCYTE-INC-26786499/news/MaxCyte-Signs-Strategic-Platform-License-with-Be-Biopharma-to-Support-the-Development-of-Engineered-46350670/?utm_source=telegram&utm_medium=social&utm_campaign=share